Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004265 |
ID: | TCMBANKHE004265 |
植物拉丁名: |
|
功能与主治: | To quiet spirit and resolve depression, quicken blood and disperse welling abscess./Disquieted heart spirit, depression, insomnia, welling abscess and sores, knocks and falls. |
药用植物名: | 合欢皮 |
药用部位: | bark |
药味: | Mild; Sweet |
经络: | Liver; Heart |
临床特征: | 1. Tranquilizing. 2. Promoting blood circulation. 3. Analgesic. |
治疗类型: | 安神 |
TCM_ID_id: | 3676 |
TCMSP_id: | 324 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000562 | tannins | Quebracho extract; 28F9E0DJY6; 67167-65-1; 1041198-33-7; TANNIC ACID; 61790-06-5; 1401-55-4; Tannins; Tannic acid [USP:JAN]; Acide tannique; SCHEMBL17432880; d'Acide tannique; 1041198-44-0; Gallotannic acid; 93615-37-3; UNII-28F9E0DJY6; 73891-88-0 | C27H24O18 | 636.5 g/mol | C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)O |
| TCMBANKIN001365 | julibrogenin a | 5,10-dihydroxy-3-[(2Z)-2-(hydroxymethyl)-6-methoxy-6-methylocta-2,7-dienoyl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; AC1NSX84 | C41H64O8 | CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CC(C2(CC1OC(=O)C(=CCCC(C)(C=C)OC)CO)C(=O)O)O)C)C)(C)C)O)C)C | |
| TCMBANKIN004324 | syringicacid methyl ester-4-o-β-d-apiofura-nosyl-(1→2)-β-d-glucopyranoside | C21H30O14 | COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)O)OC3C(C(CO3)(CO)O)O)OC)C(=O)OC | ||
| TCMBANKIN006586 | syringaresinol-4-o-β-d-apiofuranosyl-(1→2)-β-d-glucopyranosyl-4'-o-β-d-glucopyranoside | C39H54O22 | |||
| TCMBANKIN009028 | juliflorine | C40H75N3O2 | 630 g/mol | CC1C(CCC(N1)CCCCCCCCCCC2C=C(CN3C2CCC3)CCCCCCCCCCC4CCC(C(N4)C)O)O | |
| TCMBANKIN012260 | saponins | C55H86O24 | 1131.3 g/mol | CC=C(C)C(=O)OC1C(C2(C(CC1(C)C)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)CO)OC6C(C(C(C(O6)C(=O)O)OC7C(C(C(C(O7)CO)O)O)O)O)OC8C(C(C(C(O8)CO)O)O)O)C)CO)OC(=O)C | |
| TCMBANKIN017993 | vitamin c | D01CWN; Cell C; Ronotec 100; P 1110; Suncoat VC 40; D-threo-hex-2-enoic acid gamma-lactone; Citrovit; 2-o-(beta-d-glucopyranosyl)-ascorbic acid_qt; Juvamine; SCHEMBL13468284; Vasc; CHEBI:51384; D-Lyxoascorbic acid; CHEMBL1253320; AK481251; Chewcee; D-xyloascorbic acid; C8DQ5M1Y1E; MLS001066386; AK322241; Ascorbic acid, D-; AC1LD8K5; E 300; Scorbu C; 10504-35-5; Ascorbicacid; l(+)-ascorbic acid; ZINC100006137; L-ascorbate (vitamin C); (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one; (+)-Ascorbic acid; UNII-C8DQ5M1Y1E; Ascorbinsaure; Ceklin; VC 97; (2S)-2-[(1R)-1,2-bis(oxidanyl)ethyl]-4,5-bis(oxidanyl)furan-3-one; Vicin; L-ascorbate acid; L-ascorbic acid; L-dehydroascorbic acid; ascorbate; D-threo-hex-2-enono-1,4-lactone; Kangbingfeng; D-Ascorbic acid; Viscorin 100M; ZINC100028197; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxy-3-furanone; L-Ascorbic acid (8CI,9CI); Proscorbin Redoxon Ribena Ronotec 100; Hex-2-enonic acid gamma-lactone, L-threo; (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one; Ascorbic acid; DL-Ascorbic acid; AKOS000278050; Cebion, gamma-lactone; F91F7DA3-A3D5-4FB4-A6E7-C497C48D192A; GTPL4651; SMR000471843; Xyloascorbic acid, L-; Rontex 100; Rovimix C; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one; A828310 | C6H8O6 | 176.12 | C(C(C1C(=C(C(=O)O1)O)O)O)O |
| TCMBANKIN021325 | acacicacid lactone | C30H46O4 | 470.7 g/mol | CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CC(C26CC1OC6=O)O)C)C)(C)C)O)C)C | |
| TCMBANKIN021375 | machaerinic acid methyl ester | machaerinicacid methyl ester | C31H50O4 | CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CCC2(CC1O)C(=O)OC)C)C)(C)C)O)C)C | |
| TCMBANKIN022518 | noradrenaline | l-Norepinephrine bitartrate; 33404-26-1; l-Arterenol d-bitartrate; Norepinephrine hydrogen tartrate; 350-25-4; Benzyl alcohol, alpha-(aminomethyl)-3,4-dihydroxy-, (-)-, tartrate (1:1) (salt); API0007150; 1,2-Benzenediol, 4-((1R)-2-amino-1-hydroxyethyl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt); 341N180; L(+)-TARTARIC ACID; NOREPINEPHRINE; Noradrenalin bitartrate, l-; Arterenol bitartrate; Noradrenaline acid tartrate; MolPort-029-943-999; Norartrinal bitartrate; Levarterenol; ZW81GF408B; Norepinephrine bitartrate anhydrous; L-Noradrenaline bitartrate; 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol (L-(+))-bitartrate salt; AKOS007930222; Noradrenaline, tartrate (1:1); Norepinephrine tartrate; 73-98-3; Noradrenaline bitartrate; Noradrenaline tartrate; l-Noradrenaline tartrate; UNII-ZW81GF408B; C8H11NO3.C4H6O6; (-)-Norepinephrine bitartrate; (-)-Noradrenaline (+)-bitartrate; BG01031160; 51-40-1; 2477-42-1; Levonorepinephrine; 2595AH; l-Noradrenaline d-bitartrate; Noradrenaline hydrogen tartrate; HMS2089E22; (-)-R-Norepinephrine bitartrate; NSC 169106; 51-41-2 (Parent); API0003624; norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1); l-Arterenol bitartrate; Levarterenol bitartrate; Noradrenalin bitartrate; L-(-)-Noradrenaline (+)-bitartrate salt monohydrate; BENZYL ALCOHOL, alpha-(AMINOMETHYL)-3,4-DIHYDROXY-, (-)-, TARTRATE (1:1); 24868-01-7; 893-91-4; EINECS 200-095-0 | C8H12NO3+ | 170.19 g/mol | C1=CC(=C(C=C1C(C[NH3+])O)O)O |
| TCMBANKIN023589 | norarmepavine | L-(-)-N-norarmepavine; ZINC24717722; SMR000156290; 4-[[(1S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]phenol; BDBM50292465; CHEMBL453038; AC1OE5L2; Norarmepavine; HMS2198P24; MLS000575014 | C18H21NO3 | 299.4 g/mol | COC1=C(C=C2C(NCCC2=C1)CC3=CC=C(C=C3)O)OC |
| TCMBANKIN025110 | s-(2-carboxyethyl)-l-cysteine | C6H11NO4S | 193.22 g/mol | C(CSCC(C(=O)O)N)C(=O)O | |
| TCMBANKIN030032 | julibroside j3 | C103H163NO49 | CC1C(C(C(C(O1)OC(C)(CCC=C(C)C(=O)OC2C(OC(C(C2O)O)OC(C)(CCC=C(CO)C(=O)OC3CC4(C(CC3(C)C)C5=CCC6C7(CCC(C(C7CCC6(C5(CC4O)C)C)(C)C)OC8C(C(C(C(O8)COC9C(C(C(CO9)O)O)OC1C(C(C(CO1)O)O)O)O)O)NC(=O)C)C)C(=O)OC1C(C(C(C(O1)CO)O)O)OC1C(C(C(C(O1)C)OC1C(C(C(O1)CO)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)C=C)C)C=C)O)O)O | ||
| TCMBANKIN036661 | machaerinic acid lactone | machaerinicacid lactone | C30H46O3 | 454.7 g/mol | CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CCC26CC1OC6=O)C)C)(C)C)O)C)C |
| TCMBANKIN037161 | julibroside j14 | C101H160O48 | 2142 | ||
| TCMBANKIN037195 | Syringaresinol-4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside | ||||
| TCMBANKIN037221 | Julibroside J25 | ||||
| TCMBANKIN037668 | julibroside j5 | C101H160O49 | |||
| TCMBANKIN037708 | Julibroside J8 | C102H162O49 | 2172 | C1([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]([H])(OC(\C(\C([H])([H])O[H])=C([H])\C([H])([H])C([H])([H])[C@](C ([H])([H])[H])(O[C@]([H])(O[C@]2([H])C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]2([H])OC(\C(=C([H])\C([H])([H])C([H])([H])[C@@](C([H])([H])[H])(O[C@]([H])(O[C@]3([H])C([H])([H])[H])[C@]([H])(O[ H])[C@@]([H])(O[H])[C@]3([H])O[H])C([H])=C([H])[H])\C([H])([H])[H])=O)C([H])=C([H])[H])=O)C4([H])[H])[C@@]4(C(O[C@]([H])(O[C@]5([H])C([H])([H])O[H])[C@]([H])(O[C@]([H])(O[C@@]6([H])C([H])([H])[H])[C@] ([H])(O[H])[C@]([H])(O[C@]([H])(O[C@]7([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]7([H])O[H])[C@@]6([H])O[C@]([H])(O[C@@]8([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]8([H])O[H])[C@@]([H])(O[H ])[C@]5([H])O[H])=O)[C@]([H])(O[H])C9([H])[H])[C@@]9%10C([H])([H])[H])[C@@]%10(C([H])([H])[H])C([H])([H])C%11([H])[H])[C@@]%11([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C@]([H])(O[C@]%12([H])C( [H])([H])O[C@]([H])(O[C@]%13([H])C([H])([H])[H])[C@]([H])(O[C@]([H])(OC%14([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]%14([H])O[H])[C@@]([H])(O[H])[C@@]%13([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@] %12([H])O[H] | |
| TCMBANKIN038533 | Julibroside J21 | ||||
| TCMBANKIN039818 | Julibroside J10 | ||||
| TCMBANKIN040137 | Julibroside J15 | ||||
| TCMBANKIN042080 | Acacigenin B | 652.9 g/mol | |||
| TCMBANKIN042676 | Julibroside J7 | ||||
| TCMBANKIN043668 | Julibroside J17 | ||||
| TCMBANKIN044137 | Julibroside J18 | ||||
| TCMBANKIN044464 | julibroside j22 | C87H139NO43 | |||
| TCMBANKIN044590 | albibrissinoside b | C27H34O16 | 614.5 g/mol | COC1=CC(=CC(=C1O)OC)C(=O)OCC2(COC(C2O)OC3C(C(C(OC3OC4=CC(=C(C=C4)O)OC)CO)O)O)O | |
| TCMBANKIN044609 | Julibroside J20 | ||||
| TCMBANKIN045845 | Julibroside J11 | ||||
| TCMBANKIN046655 | julibroside j26 | C85H136O42 | |||
| TCMBANKIN047383 | Albibrissinoside A | 659 | |||
| TCMBANKIN047510 | Julibroside J23 | ||||
| TCMBANKIN047543 | julibroside j24 | C20H34O3 | CCCCCCCCC=CCC=CC=CC(CCCC(=O)O)O | ||
| TCMBANKIN047750 | julibroside j16 | C102H162O48 | CC1C(C(C(C(O1)OC(C)(CCC=C(C)C(=O)OC2C(OC(C(C2O)O)OC(C)(CCC=C(C)C(=O)OC3CC4(C(CC3(C)C)C5=CCC6C7(CCC(C(C7CCC6(C5(CC4O)C)C)(C)C)OC8C(C(C(C(O8)COC9C(C(C(C(O9)C)O)O)OC1C(C(C(CO1)O)O)O)O)O)O)C)C(=O)OC1C(C(C(C(O1)CO)O)O)OC1C(C(C(C(O1)C)OC1C(C(C(O1)CO)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)C=C)C)C=C)O)O)O | ||
| TCMBANKIN048567 | Julibroside J6 | ||||
| TCMBANKIN049406 | julibroside j27 | C96H152O46 | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3CCC4(C(C3(C)C)CCC5(C4CC=C6C5(CC(C7(C6CC(C(C7)OC(=O)C(=CCCC(C)(C=C)OC8C(C(C(C(O8)C)OC(=O)C(=CCCC(C)(C=C)O)CO)O)O)CO)(C)C)C(=O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)C)OC1C(C(C(O1)CO)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)C)C)C)O)O)O)OC1C(C(C(CO1)O)O)O)O)O | ||
| TCMBANKIN057928 | albizzin | l-albizziine | C4H9N3O3 | 147.13 g/mol | C(C(C(=O)O)N)NC(=O)N |
| TCMBANKIN059380 | aescin | escin _qt; CHEMBL1159567; escin; escin ia; escin iiia; aesci; saponins; Acid glycosides | C55H86O24 | 1131.3 g/mol | CC=C(C)C(=O)OC1C(C2(C(CC1(C)C)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)CO)OC6C(C(C(C(O6)C(=O)O)OC7C(C(C(C(O7)CO)O)O)O)O)OC8C(C(C(C(O8)CO)O)O)O)C)CO)OC(=O)C |
| TCMBANKIN059482 | macluraxanthone | C23H22O6 | 394.4 g/mol | CC1(C=CC2=C(C3=C(C(=C2O1)C(C)(C)C=C)OC4=C(C3=O)C=CC(=C4O)O)O)C | |
| TCMBANKIN059572 | acacicacid lactone | C30H46O4 | 470.7 g/mol | CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CC(C26CC1OC6=O)O)C)C)(C)C)O)C)C | |
| TCMBANKIN059878 | 5-carboxy-7-glucosyloxy-2-methyl-benzopyran-gamma-one | C17H18O10 | CC1=CC(=O)C2=C(O1)C=C(C=C2C(=O)O)OC3C(C(C(C(O3)CO)O)O)O | ||
| TCMBANKIN060148 | julibroside j12 | C104H165NO49 | CC1C(C(C(C(O1)OC(C)(CCC=C(C)C(=O)OC2C(OC(C(C2O)O)OC(C)(CCC=C(CO)C(=O)OC3CC4(C(CC3(C)C)C5=CCC6C7(CCC(C(C7CCC6(C5(CC4O)C)C)(C)C)OC8C(C(C(C(O8)COC9C(C(C(C(O9)C)O)O)OC1C(C(C(CO1)O)O)O)O)O)NC(=O)C)C)C(=O)OC1C(C(C(C(O1)CO)O)O)OC1C(C(C(C(O1)C)OC1C(C(C(O1)CO)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)C=C)C)C=C)O)O)O | ||
| TCMBANKIN060149 | julibroside | C101H160O49 | CC1C(C(C(C(O1)OC(C)(CCC=C(C)C(=O)OC2C(OC(C(C2O)O)OC(C)(CCC=C(CO)C(=O)OC3CC4(C(CC3(C)C)C5=CCC6C7(CCC(C(C7CCC6(C5(CC4O)C)C)(C)C)OC8C(C(C(C(O8)COC9C(C(C(CO9)O)O)OC1C(C(C(CO1)O)O)O)O)O)O)C)C(=O)OC1C(C(C(C(O1)CO)O)O)OC1C(C(C(C(O1)C)OC1C(C(C(O1)CO)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)C=C)C)C=C)O)O)O | ||
| TCMBANKIN061551 | norarmepavine | n-norarmepavine; L-(-)-N-norarmepavine; ZINC24717722; SMR000156290; 4-[[(1S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]phenol; BDBM50292465; CHEMBL453038; AC1OE5L2; Norarmepavine; HMS2198P24; MLS000575014 | C18H21NO3 | 299.4 g/mol | COC1=C(C=C2C(NCCC2=C1)CC3=CC=C(C=C3)O)OC |
| TCMBANKIN061949 | julibroside j2 | None | None |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab